Displaying drugs 1901 - 1925 of 2319 in total
Salix alba bark volatile oil
Salix alba bark volatile oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Matched Description: … Salix alba bark volatile oil is a plant/plant extract used in some OTC (over-the-counter) products. …
Bacillus amyloliquefaciens
Experimental
Indium
Indium has been used in trials studying the basic science of Clear Cell Renal Cell Carcinoma.
Investigational
Matched Salts cas: … 25114-58-3 ... 13770-61-1 …
Aguracingene cadoparvovec
Investigational
Inaticabtagene Autoleucel
Investigational
PIKA rabies vaccine
PIKA rabies vaccine is a novel vaccine developed by YS Biopharma.
Investigational
Matched Description: … PIKA rabies vaccine is a novel vaccine developed by YS Biopharma. …
Gavocabtagene autoleucel
Gavocabtagene autoleucel is a novel cell therapy consisting of autologous genetically engineered T cells expressing a single-domain antibody that recognizes human Mesothelin, fused to the CD3-epsilon subunit which, upon expression, is incorporated into the endogenous T cell receptor (TCR) complex.
Investigational
Matched Description: … Gavocabtagene autoleucel is a novel cell therapy consisting of autologous genetically engineered T cells ... expressing a single-domain antibody that recognizes human Mesothelin, fused to the CD3-epsilon subunit …
Epafipase
Epafipase is under investigation in clinical trial NCT00037687 (Safety and Efficacy of Recombinant Human Platelet-activating Factor Acetylhydrolase for the Treatment of Severe Sepsis).
Investigational
Silver oxide
Experimental
Bungarus candidus antivenom
Experimental
Incomplete Freund's adjuvant
Investigational
N-Cyclohexyl-N'-(Propyl)Phenyl Urea
Experimental
Matched Iupac: … 1-cyclohexyl-3-(3-phenylpropyl)urea …
Adlinacogene civaparvovec
Adlinacogene civaparvovec is an investigational in vivo genome editing therapeutic product. It uses proprietary zinc finger nuclease (ZFN) genome editing to insert into the DNA of liver cells a copy of the F9 gene, which controls the production of Factor IX. Developed by Sangamo Therapeutics Inc., it is being investigated...
Experimental
Matched Description: … It uses proprietary zinc finger nuclease (ZFN) genome editing to insert into the DNA of liver cells a …
Zevorcabtagene autoleucel
Investigational
Pegcrisantaspase
Pegcrisantaspase is under investigation in clinical trial NCT02257684 (A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)).
Investigational
Matched Description: … Pegcrisantaspase is under investigation in clinical trial NCT02257684 (A Dose Confirmation and Pharmacokinetic …
Furazabol
Illicit
Matched Iupac: … (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6-oxa-5,7-diazapentacyclo[11.7.0.0^{2,10}.0^{4,8}.0^{14,18 …
Autologous pancreatic islets
Autologous pancreatic islet therapy involves isolating the patient's own insulin-producing cells.
Investigational
Deoxynucleogene ancparvovec
Investigational
Melaleuca alternifolia leaf
Melaleuca alternifolia leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Matched Description: … Melaleuca alternifolia leaf is a plant/plant extract used in some OTC (over-the-counter) products. …
Atractylodes japonica root oil
Atractylodes japonica root oil is obtained from the roots of Atractylodes japonica, which is a herb native to eastern Asia. It is present in some cosmetic products such as whitening creams as an active ingredient and lubricant for skin irritation. Atractylodes japonica is reported to have anti-inflammatory and antinociceptive effects...
Experimental
Matched Description: … Atractylodes japonica root oil is obtained from the roots of Atractylodes japonica, which is a herb native …
Tetanus immune globulin, equine
Experimental
Enibarcimab
Enibarcimab is under investigation in clinical trial NCT03989531 (Adrecizumab in Cardiogenic Shock).
Investigational
Allogeneic umbilical cord mesenchymal stem cells
Investigational
Dihydroxyaluminum sodium carbonate
Experimental
METHOXYUNDECYLPHOSPHINIC ACID
Experimental
Displaying drugs 1901 - 1925 of 2319 in total